Oral tolerance and its modulation by anti-cytokines

Research in Immunology

Volumn 148, Issue 8-9, 1997, Pages 554-561

  Marth, T ^a   Strober, W ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CLONAL ANERGY; CYTOKINE PRODUCTION; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 0031252239     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80149-1     Document Type: Article

References (64)

1. [1] Ferguson, A., Gillett, H. & Mahony, S. (1996), Active immunity or tolerance to foods in patients with celiac disease or inflammatory bowel disease. Ann. N. Y. Acad. Sci., 778, 202-216.
2. [2] Mowat, A. (1987), The regulation of immune responses to dietary protein antigens. Immunol. Today, 8, 93-98.
3. [3] Weiner, H., Friedman, A., Miller, A., Khoury, S., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, M., Trentham, D. & Hafler, D. (1994), Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol., 12, 809-837.
4. [4] Strobel, S. & Ferguson, A. (1987), Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology, 60, 317-318.
5. [5] Mowat, A., Strobel, S., Drummond, H. & Ferguson, A. (1982), Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology, 45, 105-113.
6. [6] Challacombe, S. & Tomasi, J. (1980), Systemic tolerance and secretory immunity after oral immunisation. J. Exp. Med., 152, 1459-1472.
7. [7] Kay, R. & Ferguson, A. (1989), The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology, 66, 416-421.
8. [8] Lamont, A., Gordon, M. & Ferguson, A. (1987), Oral tolerance in protein-deprived mice. I. Profound antibody tolerance but impaired DTH tolerance after antigen feeding. Immunology, 61, 333-337.
9. [9] Lamont, A., Bruce, M., Watret, K. & Ferguson, A. (1988), Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology, 64, 135-140.
10. [10] Marth, T., Strober, W. & Kelsall, B. (1996), High dose oral tolerance in ovalbumin TCR transgenic mice: systemic neutralization of interleukin-1.2 augments TGFβ secretion and T cell apoptosis. J. Immunol., 157, 2348-2357.
11. [11] Mowat, A. (1994), Oral tolerance and regulation of immunity to dietary antigens, in "Handbook of Mucosal Immunology" (Ogra, P., Lamm, M., McGhee, J., Mestecky, J., Strober, W. and Bienenstock, J.) (pp. 185-201), Academic Press, San Diego, CA.
12. [12] MacDonald, T. (1983), Immunosuppression caused by antigen feeding. - II. Suppressor T cells mask Peyer's patches B cell priming to orally administered antigen. Eur. J. Immunol., 13, 138-142.
13. [13] Mattingly, J. (1984), Immunological suppression after oral antigen adminstration. - III. Activation of suppressor-inducer cells in the Peyer's patches. Cell Immunol., 86, 46-52.
14. [14] Santos, L., Al-Sabbagh, A., Londono, A. & Weiner, H. (1994), Oral tolerance to myelin basic protein induces regulatory TGF-beta secreting cells in Peyer's patches of SJL mice. Cell Immunol., 157, 439-447.
15. [15] Mattingly, J. & Waksman, B. (1978), Immunologic suppression after oral administration of antigen. -I. Specific suppressor cells formed in rat Peyers patches after oral administration of sheep erythrocytes and their systemic migration. J. Immunol., 121, 1878-1883.
16. [16] MacDonald, T. (1982), Immunosuppression caused by antigen feeding. - I. Evidence for the activation of a feedback suppressor pathway in the spleens of antigen-fed mice. Eur. J. Immunol., 12, 767-773.
17. [17] Mosmann, T. & Coffman, R. (1989), TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol., 7, 145-173.
18. [18] Seder, R. & Paul, W. (1994), Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol., 12, 635-673.
19. [19] Strober, W., Kelsall, B. & Marth, T. (1998), Oral tolerance. J. Clin. Immunol. (in press).
20. [20] Bruce, M. & Ferguson, A. (1986), The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology, 59, 295-300.
21. [21] Peng, H., Turner, M. & Ferguson, A. (1990), The generation of a tolerogen after a feed of ovalbumin is time-dependent and unrelated to the serum level of immunoreactive protein. Clin. Exp. Immunol., 81, 510-515.
22. [22] Strobel, S., Mowat, A., Drummond, H., Pickering, M. & Ferguson, A. (1983), Immunological responses to fed protein antigens in mice. - II. Oral tolerance for CMI is due to activation of cyclophosphamide sensitive cells by gut-processed antigen. Immunology, 49, 451-456.
23. [23] Hanson, D., Roy, M., Green, G. & Miller, S. (1993), Inhibition of orally induced immune tolerance in mice by prefeeding an endopeptidase inhibitor. Reg. Immunol., 5, 85-93.
24. [24] Mowat, A., Thomas, J. & Parrott, D. (1986), Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particular antigens in mice. Immunology, 58, 677-684.
25. [25] Mowat, A., Maloy, K. & Donachie, A. (1993), Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens. Immunology, 80, 527-534.
26. [26] Mowat, A. & Parrott, D. (1983), Immunological responses to fed protein antigens in mice. - IV. Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin. Immunology, 50, 547-554.
27. [27] Mowat, A., Lamont, A. & Bruce, M. (1988), Suppressor T cells, antigen-presenting cells and the role of I-J restriction in oral tolerance to ovalbumin. Immunology, 64, 141-145.
28. [28] Strobel, S., Mowat, A. & Ferguson, A. (1985), Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during graft-versus-host reaction in mice. Immunology, 56, 57-64.
29. [29] Schwartz, R. (1993), Immunological tolerance, in "Fundamental Immunology" (Paul W., ed.) (pp. 677-731). Raven Press, New York.
30. [30] Thomas, H., Ryan, C., Benjamin, I., Blumgart, L. & MacSween, R. (1976), The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens. Gastroenterology, 71, 114-117.
31. [31] Chase, M. & Battisto, J. (1955), The duration of dermal sensitization following cellular transfer in guinea pigs. J. Allergy, 26, 83.
32. [32] Miller, A., Lider, O. & Weiner, H. (1991), Antigen-driven bystander suppression after oral administration of antigen. J. Exp. Med., 174, 791-798.
33. [33] Khoury, S., Hancock, W. & Weiner, H. (1992), Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med., 176, 1355-1364.
34. [34] Miller, A., Lider, O., Roberts, A., Sporn, M. & Weiner, H. (1992), Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA, 89, 421-425.
35. [35] Link, J., He, B., Navikas, V., Palasik, W., Fredrikson, S., Soderstrom, S. & Link, H. (1995), Transforming growth factor beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin 10 in multiple sclerosis and myasthenia gravis. J. Neuroimmunol., 58, 21-35.
36. [36] Whitacre, C., Gienapp, I., Orosz, C. & Bitar, D. (1991), Oral tolerance in experimental autoimmune encephalitis. - III. Evidence for clonal anergy. J. Immunol., 147, 2155-2163.
37. [37] Friedman, A. & Weiner, H. (1994), Induction of anergy or active suppression in oral tolerance is determined by frequency of feeding and antigen dosage. Proc. Natl. Acad. Sci. USA, 91, 6688-6692.
38. [38] Chen, Y., Inobe, J., Marks, R., Gonella, P., Kuchroo, V. & Weiner, H. (1995), Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature, 376, 177-180.
39. [39] Thorbecke, G., Shah, R., Leu, C., Kuruvilla, A., Hardison, A. & Palladino, M. (1992), Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA, 89, 7375-7379.
40. [40] Karpus, W. & Swanborg, R. (1991), CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor β. J. Immunol., 146, 1163-1169.
41. [41] Neurath, M., Fuss, I., Kelsall, B., Presky, D., Waegell, W. & Strober, W. (1996), Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J. Exp. Med., 183, 2605-2616.
42. [42] Galliaerde, V., Desvignes, C., Peyron, E. & Kaiserlian, D. (1995), Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorbenzene-fed mice inhibit hapten-specific T cell activation in vitro. Eur. J. Immunol., 25, 1385-1390.
43. [43] Chen, Y., Inobe, J. & Weiner, H. (1995), Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J. Immunol., 155, 910-916.
44. [44] Lider, O., Santos, L., Lee, C., Higgins, P. & Weiner, H. (1989), Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. - II. Suppression of disease and in vitro responses is mediated by antigen-specific CD8+ T lymphocytes. J. Immunol., 142, 748-752.
45. [45] Fukaura, H., Kent, S., Pietrusewic, M., Khoury, S., Weiner, H. & Hafler, D. (1996), Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest., 98, 70-77.
46. [46] Chen, Y., Kuchroo, V., Inobe, J., Hafler, D. & Weiner, H. (1994), Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalitis. Science, 265, 1237-1240.
47. [47] Chen, Y., Inobe, J., Kuchroo, V., Baron, J., Chaneway, C. &Weiner, H. (1996), Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA, 93, 388-391.
48. [48] Muller, G., Saloga, J., Germann, T., Schuler, G., Knop, J. & Enk, A. (1995), IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J. Immunol., 155, 4661-4668.
49. [49] Riemann, H., Schwarz, A., Grabbe, S., Aragane, Y., Luger, T., Wysocka, M., Kubin, M., Trimchieri, G. & Schwarz, T. (1996), Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J. Immunol., 156, 1799-1803.
50. [50] Claessen, A., von Blomberg, B., De Groot, J., DA, W., G, K. & RJ, S. (1996), Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization. Immunology, 88, 363-367.
51. [51] Marth, T., Strober, W., Seder, R. & Kelsall, B. (1997), Regulation of transforming growth factor beta production by interleukin-12. Eur. J. Immunol., 27, 1213-1220.
52. [52] Strober, W., Kelsall, B., Fuss, I., Marth, T., Ludviksson, B., Ehrhardt, R. & Neurath, M. (1997), Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol. Today, 18, 61-64.
53. [53] Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rüde, E. & Germann, T. (1994), T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-β. Eur. J. Immunol., 24, 793-798.
54. [54] Neurath, M., Fuss, I., Kelsall, B., Stüber, E. & Strober, W. (1995), Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med., 182, 1281-1290.
55. [55] Zhang, Z. & Michael, J. (1990), Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment. J. Immunol., 144, 4163-4165.
56. [56] Kjerrulf, M., Grdic, D., Ekman, L., Schon, K., Vajdy, M. & Lycke, N. (1997), Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology, 92, 60-68.
57. [57] Boissier, M., Chiocchia, G., Bessis, N., Hajnal, J., Garotta, G., Nicoletti, F. & Fournier, C. (1995), Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur. J. Immunol., 25, 1184-1190.
58. [58] Kweon, H., Fujihashi, K., Yamamoto, M., van Cott, J., McGhee, J. & Kiyono, H. (1996), Mucosally induced tolerance in IL-4 -/-but not IFN-gamma -/-mice. FASEB J., 10, A1028.
59. [59] Zhang, Z., Davidson, L., Eisenbarth, G. & Weiner, H. (1991), Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA, 88, 10252-10256.
60. [60] Hancock, W., Polanski, M., Hhang, Z., Blogg, N. & Weiner, H. (1995), Suppression of insulinitis in NOD mice by oral insulin administration is associated with selective expression of IL-4, IL-10, TGF-beta and prostaglandin-E. Am. J. Pathol., 147, 1193-1199.
61. [61] Inobe, J., Chen, Y. & Weiner, H. (1996), In vivo administration of IL-4 induces TGF-beta producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci., 778, 390-392.
62. [62] Garside, P., Steel, E., Worthey, A., Satoskar, A., Alexander, J., Bluethmann, H., Liew, F. & Mowat, A. (1995), Th2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol., 154, 3549-3555.
63. [63] Vajdy, M., Kosco-Vilbois, M., Kopf, M., Kohler, G. & Lycke, N. (1995), Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med., 181, 41-53.
64. [64] Aroeira, L., Cardillo, F., De Albuquerque, D., Vaz, N. & Mengel, J. (1995), Anti-IL-10 treatment does not block either the induction or the maintenance of orally induced tolerance to OVA. Scand. J. Immunol., 41, 319-323.